What Are The 5 KPIs For Total Artificial Heart Program?
Total Artificial Heart Program
KPI Metrics for Total Artificial Heart Program
The Total Artificial Heart Program operates under extreme financial and clinical pressure, requiring precise Key Performance Indicator (KPI) tracking across capacity, cost, and patient outcomes You must monitor seven core metrics monthly to manage the high fixed overhead of $225,500 per month for facilities and compliance Initial revenue in 2026 is projected at $129 million, but this depends on achieving a 40% utilization rate for Cardiac Surgeons and maintaining variable costs-TAH devices and consumables-at 150% of revenue The program reaches break-even almost immediately (January 2026), but requires 15 months to pay back the initial capital expenditure (CapEx) Focus on maximizing Procedure Volume per Surgeon and tightly controlling the Gross Margin Percentage (target 75-80%) Review financial metrics weekly and clinical capacity metrics daily
7 KPIs to Track for Total Artificial Heart Program
#
KPI Name
Metric Type
Target / Benchmark
Review Frequency
1
Procedure Volume per Surgeon
Throughput
2 procedures/surgeon/month in 2026
Weekly
2
Gross Margin Percentage (GM%)
Margin Ratio
800% (since COGS is 150%)
Monthly
3
Key Staff Capacity Utilization
Utilization Rate
400% (Surgeons, 2026)
Monthly
4
Fixed Cost Coverage Ratio
Coverage Ratio
>15x
Monthly
5
Months to Payback
Recovery Time
15 months (based on model)
Quarterly
6
TAH Device Cost Percentage
Cost Ratio
120% (2026), trending down to 100% by 2030
Quarterly
7
Return on Equity (ROE)
Equity Return
>100% (model projects 18126%)
Annually
Total Artificial Heart Program Financial Model
5-Year Financial Projections
100% Editable
Investor-Approved Valuation Models
MAC/PC Compatible, Fully Unlocked
No Accounting Or Financial Knowledge
What is the primary bottleneck limiting our revenue growth and how do we measure it?
The primary constraint on the Total Artificial Heart Program's revenue growth is the capacity of your specialized surgical team, which you must measure against the $450,000 average procedure price; understanding this constraint is foundational to your operational roadmap, which you can detail further when you learn How Do I Write A Business Plan To Launch Total Artificial Heart Program?
Identify the Constrained Resource
Surgical time is your fixed asset limiting patient throughput.
Cardiac Surgeon utilization is projected to hit 400% in 2026.
This means demand is four times the available surgeon time.
You must hire or delegate immediately to capture revenue.
Measure Capacity Value
Track procedures performed versus surgeon hours available.
Each successful TAH implantation generates $450,000 revenue.
Calculate lost revenue: (Projected Capacity - Actual Capacity) x $450k.
If you can't staff for 400% utilization, that's your revenue gap.
How do we maintain strong margins despite high device and fixed operating expenses?
Maintaining margins for the Total Artificial Heart Program requires aggressively cutting variable costs, especially the device kits that currently cost 120% of revenue, to build enough contribution margin to absorb the $27 million annual fixed operating expenses; this is critical for long-term viability, which you can explore further in How Increase Profitability Of Total Artificial Heart Program?
Crush Variable Cost Drag
Device kits alone represent 120% of revenue, making contribution margin negative initially.
Demand volume commitments from suppliers for better unit pricing.
Focus on maximizing the recurring revenue from long-term device management.
Every dollar saved on the kit cost immediately flows to covering overhead.
Covering Fixed Overhead
Fixed operating expenses run $27,000,000 per year.
You must drive high practitioner utilization rates for implants and follow-ups.
This requires defintely high procedure volume to spread that fixed cost base.
Secure partnerships with hospital systems to ensure a steady patient pipeline.
Are we efficiently utilizing our specialized staff and capital expenditures?
You must track staff utilization against planned capacity to ensure the $775 million CapEx investment pays off defintely. If Critical Care Nurses are projected at 600% utilization by 2026, you need immediate checks on scheduling efficiency now.
When will the program become self-funding and what is the maximum cash drawdown we face?
The Total Artificial Heart Program achieves operational break-even in just 1 month, but you must manage liquidity closely becuase the maximum cash drawdown hits -$3,387 million in June 2026, requiring a 15-month payback period; understanding this cash flow profile is key before you decide How Much To Start A Total Artificial Heart Program?
Path to Self-Funding
Operational break-even hits in 1 month.
Full capital payback takes 15 months.
Focus on hitting initial utilization targets fast.
This timeline assumes smooth revenue recognition.
Liquidity Risk Management
Track minimum cash point: -$3,387 million.
This low point is projected for June 2026.
Ensure sufficient runway beyond this date.
Liquidity management is your primary near-term risk.
Total Artificial Heart Program Business Plan
30+ Business Plan Pages
Investor/Bank Ready
Pre-Written Business Plan
Customizable in Minutes
Immediate Access
Key Takeaways
Successfully scaling requires achieving the target 75-80% Gross Margin by aggressively controlling variable costs, especially TAH device expenses which currently exceed revenue.
Despite rapid break-even in one month, the 15-month capital payback period necessitates rigorous cash flow management to navigate the projected minimum cash drawdown of -$3.387 million.
The primary constraint on revenue growth is specialized staff capacity, requiring intense monitoring of utilization rates, such as the starting 400% utilization for Cardiac Surgeons.
Managing the program's high fixed overhead ($225,500 monthly) and maximizing Procedure Volume per Surgeon are essential operational drivers for covering fixed costs and ensuring long-term viability.
KPI 1
: Procedure Volume per Surgeon
Definition
Procedure Volume per Surgeon measures surgical throughput, showing how many Total Implants each Cardiac Surgeon completes over a set period. This metric is crucial for capacity planning and ensuring specialized staff utilization meets operational targets. You're aiming for 2 procedures/surgeon/month by 2026.
Advantages
Identifies bottlenecks in the operating room schedule flow.
Directly links staffing levels to revenue generation potential.
Helps forecast future hiring needs accurately for specialized teams.
Disadvantages
High volume might mask declining quality or complication rates.
Doesn't account for procedure complexity or required surgeon time.
Can create pressure to schedule marginal or borderline cases.
Industry Benchmarks
For highly specialized procedures like Total Artificial Heart (TAH) implantation, throughput benchmarks are often lower than general surgery due to the intensity of care required. While general benchmarks might suggest 4-6 cases per surgeon monthly, centers of excellence often target 2 procedures/surgeon/month initially, as set for 2026. Hitting this target shows effective deployment of highly specialized resources.
How To Improve
Streamline pre-operative clearance timelines to reduce surgeon downtime.
Implement standardized surgical pathways to reduce case variability.
Review operating room turnover times weekly to free up surgeon capacity.
How To Calculate
You calculate this by dividing the total number of implants performed by the total number of cardiac surgeons available to perform them in that period. This gives you the average throughput per provider.
Example of Calculation
To hit the 2026 target of 2 procedures/surgeon/month, if you have 8 Cardiac Surgeons, you need 16 Total Implants that month. Here's the quick math for hitting that goal:
16 Total Implants / 8 Cardiac Surgeons = 2.0 Procedures/Surgeon/Month
If you only hit 14 implants, your actual volume is 1.75, which needs immediate attention in your weekly review.
Tips and Trics
Track volume daily, not just monthly, for quick course correction.
Segment volume by procedure type if complexity varies widely.
Ensure surgeon count reflects only active, full-time equivalents; don't count surgeons on extended leave.
Tie utilization reviews defintely to the weekly schedule meeting agenda.
KPI 2
: Gross Margin Percentage (GM%)
Definition
Gross Margin Percentage (GM%) shows how much revenue remains after paying for the direct costs associated with delivering your service. For the Total Artificial Heart Program, this metric is your primary check on cost control over expensive TAH devices and necessary consumables. Hitting your target is defintely key to covering all your fixed operating expenses.
Advantages
Pinpoints spending on TAH devices and supplies.
Shows pricing power versus direct expenses.
Drives monthly focus on cost reduction efforts.
Disadvantages
Ignores fixed costs like facility overhead.
Can be skewed by one-time bulk device purchases.
Doesn't reflect patient outcome quality, only cost efficiency.
Industry Benchmarks
Standard GM% in many service industries runs between 40% and 70%. However, your internal target here is 800%, which suggests you are measuring this metric against a very specific internal definition, especially since your Cost of Goods Sold (COGS) is expected to run at 150% of revenue. You must review this monthly because large device costs can swing this number quickly.
How To Improve
Negotiate better volume discounts on TAH devices.
Standardize consumable kits to reduce waste.
Increase procedure efficiency to lower labor time per case.
How To Calculate
Gross Margin Percentage is calculated by taking your total revenue, subtracting the direct costs (COGS), and dividing that result by revenue. This metric is crucial for understanding the direct profitability of each patient interaction.
GM% = (Revenue - COGS) / Revenue
Example of Calculation
If you generate $500,000 in monthly revenue from procedures and ongoing management, and your direct costs (COGS), primarily the TAH devices and consumables, total $750,000 (which is 150% of revenue), here is how you apply the formula based on your stated inputs.
GM% = ($500,000 - $750,000) / $500,000 = -50%
While the standard calculation yields a negative result here, your internal target is set at 800%. This means you must reconcile what specific costs are excluded from COGS or how revenue is defined to reach that 800% goal.
Tips and Trics
Review this metric every single month without fail.
Compare device cost against Procedure Volume per Surgeon.
Track TAH Device Cost Percentage separately for context.
If GM% drops, immediately audit supply chain invoicing.
KPI 3
: Key Staff Capacity Utilization
Definition
Key Staff Capacity Utilization measures how effectively you deploy your specialized clinical staff, like surgeons, against their maximum potential output. For CardiaNova, this is vital because high fixed costs demand that specialized personnel operate near peak efficiency to cover the investment in the Total Artificial Heart (TAH) program.
Advantages
Maximizes return on investment in highly specialized, expensive surgeons.
Directly links staff deployment to achieving projected revenue targets.
Disadvantages
Over-focusing can push staff past sustainable limits, risking burnout.
It doesn't account for procedure complexity or patient acuity variations.
A target like 400% might mask poor resource allocation if not tied to quality.
Industry Benchmarks
In specialized medical fields, utilization often surpasses 100% because the calculation accounts for multiple roles or high-intensity scheduling. A target of 400% for surgeons in 2026 suggests that through efficient scheduling and delegation, one surgeon's time is effectively leveraged four times over the baseline capacity. This aggressive target needs validation against peer outcomes in TAH centers.
How To Improve
Standardize pre-operative protocols to cut setup time per case.
Cross-train nurses and technicians to handle more device management tasks.
Optimize operating room block scheduling to minimize idle time between procedures.
How To Calculate
You calculate Key Staff Capacity Utilization by dividing the actual number of procedures performed by the maximum number of procedures your staff could theoretically handle in the same period. This metric is reviewed monthly.
Procedures Performed / Maximum Possible Procedures
Example of Calculation
Suppose your modeling shows that your current surgical team has the capacity to handle 10 TAH implant procedures per month under ideal conditions (Maximum Possible Procedures). If your team actually completes 40 procedures that month, your utilization is 400%. Here's the quick math:
40 Procedures Performed / 10 Maximum Possible Procedures = 4.0 or 400%
. Still, you must ensure that this high volume doesn't compromise the quality of long-term device management.
Tips and Trics
Track utilization against the 400% target every 30 days.
Defintely link utilization incentives to patient safety scores, not just volume.
Isolate time spent on non-billable tasks like physician training.
If utilization falls below 350% for two consecutive months, flag it for immediate review.
KPI 4
: Fixed Cost Coverage Ratio
Definition
The Fixed Cost Coverage Ratio (FCCR) shows how many times your Contribution Margin pays for your Total Fixed Operating Expenses. This metric tells you your safety cushion above covering overhead. For a high-fixed-cost operation like specialized heart care, you must target a ratio greater than 15x, reviewing this number monthly.
Shows if revenue growth is outpacing overhead creep.
Disadvantages
Ignores the actual cash needed for CapEx.
A high ratio might mean you are understaffed.
It hides poor pricing if CM is inflated by high fees.
Industry Benchmarks
For specialized medical centers relying on high-value procedures, benchmarks vary widely based on facility ownership structure. A target above 15x is aggressive, suggesting you have very few fixed costs relative to the high fees charged for TAH implantation and management. If your ratio falls below 5x, you are definitely running a high risk of insolvency if procedure volume dips.
How To Improve
Increase surgeon utilization without hiring new fixed staff.
Renegotiate long-term fixed contracts like facility leases.
Raise service prices to boost the contribution margin per procedure.
How To Calculate
You find this ratio by dividing your total monthly contribution margin by your total monthly fixed operating expenses. This calculation requires you to clearly separate variable costs, like device consumables, from fixed costs, like administrative salaries.
Fixed Cost Coverage Ratio = Contribution Margin / Total Fixed Operating Expenses
Example of Calculation
Say your specialized institute generates a Contribution Margin of $2,250,000 after accounting for variable costs associated with TAH procedures. If your Total Fixed Operating Expenses-salaries for non-surgical admin, rent, utilities-are $150,000 for the month, here is the math.
FCCR = $2,250,000 / $150,000 = 15.0x
In this scenario, you hit the minimum target exactly. If CM rose to $2.4 million next month, the ratio would improve.
Track this ratio against Key Staff Capacity Utilization monthly.
If utilization is low, fixed costs are too high for current volume.
If the ratio dips below 12x, defintely review all non-clinical overhead spending.
KPI 5
: Months to Payback
Definition
Months to Payback shows you exactly how long it takes for your business cash flow to cover the initial big spending, the capital expenditure (CapEx). This metric is crucial because it measures the speed at which your investment becomes self-funding. For this specialized heart institute, the internal model targets a recovery time of 15 months.
Advantages
Quickly assesses investment viability against risk tolerance.
Helps set realistic timelines for achieving positive cash flow.
Informs decisions on scaling up or delaying further CapEx deployment.
Disadvantages
It's highly sensitive to initial CapEx estimates.
It ignores profitability metrics after the payback period ends.
It relies entirely on projected Free Cash Flow, which can shift.
Industry Benchmarks
In specialized medical fields requiring heavy initial investment in unique surgical technology, payback periods often stretch longer than in standard service businesses. While 15 months is an aggressive goal, anything over 30 months signals serious capital drag. You must compare this against the expected lifespan of the core technology you are buying.
How To Improve
Increase procedure volume per surgeon to drive revenue faster.
Aggressively manage working capital to improve monthly cash flow.
Challenge initial CapEx assumptions; can leasing reduce upfront cost?
How To Calculate
To find this time, you take the total amount spent on long-term assets and divide it by the average monthly cash flow you expect to generate after paying all operating costs. This calculation shows the recovery timeline for your initial outlay.
Months to Payback = Total CapEx / Average Monthly Free Cash Flow
Example of Calculation
Say your total initial investment for the specialized center, including the TAH devices and facility build-out, is estimated at $15 million. To hit the 15-month target, your model must project that the business generates $1 million in Free Cash Flow every month.
Months to Payback = $15,000,000 / $1,000,000 per month = 15 Months
Tips and Trics
Review this metric quarterly, as specified in the plan.
Ensure CapEx includes all soft costs like initial training and certification.
If utilization rates drop, the payback period will defintely extend.
Track the components driving Free Cash Flow, like the Gross Margin Percentage.
KPI 6
: TAH Device Cost Percentage
Definition
The TAH Device Cost Percentage shows what share of your total revenue goes just to buying the Total Artificial Heart devices. This metric tracks your single largest variable expense, which is crucial because these devices are incredibly expensive. If this number is too high, your ability to cover fixed costs and make money disappears fast.
Advantages
Immediately flags when device procurement costs spike unexpectedly.
Drives focused negotiation strategy with the device supplier.
Helps forecast future profitability based on device price stability.
Disadvantages
It doesn't account for the cost of specialized consumables used during surgery.
A low percentage might hide poor revenue capture if procedures are underbilled.
It's highly sensitive to the timing of large, infrequent device purchases.
Industry Benchmarks
For specialized medical centers like yours, general industry benchmarks don't really apply; this metric is almost entirely internal. Your target trajectory-starting at 120% in 2026 and aiming for 100% by 2030-is your benchmark. This implies that initially, the cost of the device exceeds the revenue recognized for the procedure, which is a tough spot that needs aggressive management.
How To Improve
Secure multi-year volume commitments to lock in lower unit pricing.
Improve surgeon throughput (KPI 1) to spread fixed device costs over more billable procedures.
Review reimbursement coding quarterly to ensure maximum revenue capture per implant.
How To Calculate
You calculate this by taking the total cost paid for all TAH devices during the period and dividing it by the total revenue generated from all related services that period. This is a key metric for understanding your baseline cost structure.
TAH Device Cost Percentage = (Total TAH Device Cost / Total Revenue) x 100
Example of Calculation
Let's look at your 2026 target scenario. Say your center performs enough procedures to generate $10 million in Total Revenue for the year. To hit the 120% target, the cost of the devices purchased must equal 120% of that revenue.
TAH Device Cost Percentage = ($12,000,000 TAH Device Cost / $10,000,000 Total Revenue) x 100 = 120%
If the device cost was only $9 million, the percentage would be 90%, meaning you'd be ahead of schedule for 2030. Honestly, getting this below 100% is where you start making real money.
Tips and Trics
Review this metric defintely on a quarterly basis as planned.
Isolate device costs from general surgical supply costs immediately.
Track the cost per unit against the average reimbursement rate per procedure.
If the percentage rises above 120% in any quarter, flag it for immediate executive review.
KPI 7
: Return on Equity (ROE)
Definition
Return on Equity (ROE) shows how well the business uses the money owners put in to make a profit. It's the main gauge of management effectiveness regarding shareholder capital. For this specialized heart institute, the model projects a massive 18126% ROE.
Advantages
Shows true efficiency of owner capital deployment.
Signals strong profitability to potential future investors.
Disadvantages
Can be skewed by high levels of debt financing.
Doesn't account for operational risk exposure in complex surgery.
High ROE might hide poor working capital management.
Industry Benchmarks
For established, stable healthcare providers, a healthy ROE often sits above 15%. However, for high-growth, capital-intensive centers like this one, targets are much higher, like the >100% goal set here. This metric tells investors if the specialized TAH center is generating outsized returns on their invested capital.
How To Improve
Boost Net Income by maximizing practitioner utilization.
Minimize shareholder equity through strategic debt financing.
Aggressively manage operating expenses to increase the numerator.
How To Calculate
You calculate ROE by dividing the company's Net Income by the total Shareholder Equity. This shows the return generated for every dollar of equity capital invested in the business.
Return on Equity = Net Income / Shareholder Equity
Example of Calculation
To see what the projected 18126% ROE means operationally, let's use a hypothetical equity base. If the institute has $1,000,000 in Shareholder Equity, the projected Net Income required to hit that target must be $181,260. This demonstrates the high level of profit generation expected relative to owner investment.
The most critical metrics are Gross Margin (target >75%), Fixed Cost Coverage, and Months to Payback, which is projected at 15 months due to the $775 million in initial CapEx
This program is projected to reach break-even quickly, within 1 month (January 2026), driven by high procedure prices and efficient cost management
The TAH Device and Surgical Kits represent the largest variable cost, starting at 120% of revenue in 2026
Review capacity utilization, especially for Cardiac Surgeons (starting at 400%), monthly to ensure staffing levels match demand and maximize revenue
The program requires careful cash management, hitting a minimum cash point of -$3387 million in June 2026 before cash flow stabilizes
The projected Internal Rate of Return (IRR) is 1266%, and the Return on Equity (ROE) is exceptionally high at 18126%, indicating strong capital efficiency
About the author
Jason Burke
Business Operations Writer
Jason Burke is a business operations writer at Financial Models Lab who researches how small businesses launch, operate, and earn money, with a focus on first-year business costs and the shift from side project to real business. He writes simple business projections and practical guidance that helps non-finance readers make business planning feel clearer, more useful, and easier to act on.
Choosing a selection results in a full page refresh.
